In the absence of effective interventions to prevent preterm births, improved survival of
infants who are born at the biological limits of viability has relied on advances in perinatal …

Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease in infants and
is associated with increased mortality, respiratory morbidity, neurodevelopmental …

Oxygen therapy is common during the neonatal period to improve survival, but it can
increase the risk of oxygen toxicity. Hyperoxia can damage multiple organs and systems in …

Bronchopulmonary dysplasia (BPD) remains the most common respiratory complication of
prematurity as younger and smaller infants are surviving beyond the immediate neonatal …

In the current era, the survival of extremely low-birth-weight infants has increased
considerably because of new advances in technology; however, these infants often develop …

Bronchopulmonary dysplasia (BPD) remains the most common complication of premature
birth, imposing a significant and potentially life-long burden on patients and their families …

Bronchopulmonary Dysplasia (BPD) is a multifactorial disease affecting over 35% of
extremely preterm infants born each year. Despite the advances made in understanding the …

An increasing number of extremely premature infants survive the neonatal period and
beyond. Little is known about the maturation of the preterm infant's metabolome and its …

Lung development is not completed at birth, but expands beyond infancy, rendering the lung
highly susceptible to injury. Exposure to various influences during a critical window of organ …

Objective To quantify and compare levels of potential biomarkers in neonates with (i)
Bronchopulmonary dysplasia (BPD);(ii) BPD-associated pulmonary hypertension (BPD …